Cargando…
Senolytic drugs relieve pain by reducing peripheral nociceptive signaling without modifying joint tissue damage in spontaneous osteoarthritis
Aging is a risk factor for the development of osteoarthritis (OA), a progressive joint disease leading to cartilage damage, pain, and loss of function. In a mouse model of OA, senolytic drugs to selectively clear senescent cells (SnCs) that accumulate with injury or aging yielded a chondroprotective...
Autores principales: | Gil, Tae-Hwan, Zheng, Haiyan, Lee, Hyo Gyeong, Shin, Ji-Won, Hwang, Sun Wook, Jang, Ki-Mo, Jeon, Ok Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417227/ https://www.ncbi.nlm.nih.gov/pubmed/35951358 http://dx.doi.org/10.18632/aging.204204 |
Ejemplares similares
-
Senolytic treatment reduces oxidative protein stress in an aging male murine model of post‐traumatic osteoarthritis
por: Chin, Alexander F., et al.
Publicado: (2023) -
Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy
por: Nogueira-Recalde, Uxía, et al.
Publicado: (2019) -
Senolytics alleviate the degenerative disorders of temporomandibular joint in old age
por: Zhou, Yueying, et al.
Publicado: (2021) -
Paradoxes of senolytics
por: Blagosklonny, Mikhail V.
Publicado: (2018) -
Senescence and Senolytics: State of the Art on Cellular Senescence, Senolytics, and Healthspan
por: Campisi, Judith
Publicado: (2020)